Dr. Joshua R. Langford, MD

Dr. Langford practices at Central Florida Orthopedic Associates IPA Inc in Orlando, Florida.

Dr. Langford's NPI, 1386771350, was assigned on February 27, 2007. Dr. Langford graduated from University of Illinois College of Medicine - Chicago in 2002. Dr. Langford holds Florida license ME 97765.

Dr. Langford's primary practice is Central Florida Orthopedic Associates IPA Inc, at 6735 Conroy Rd, Orlando, FL 32835 in Orange County. The practice phone is (407) 816-5031.

Dr. Langford's primary practice is Central Florida Orthopedic Associates IPA Inc in Orlando, Florida. Dr. Langford is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Langford to 2 more hospitals, 3 group practices and clinics, 3 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langford practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Langford's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Langford is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Langford's licenses on file in 2 states: Florida and New York.

Dmand AI lists amputation, ankle replacement, arthritis, broken or dislocated ankle/ or foot, hip replacement, joint or bone infection, joint pain and knee arthroscopy among the conditions Dr. Langford treats.

CMS data shows 491 Medicare services from Dr. Langford across 14 procedure codes in 2024, for 230 Medicare patients. Medicare paid $69,111 for them.

CMS counts 230 Medicare patients who saw Dr. Langford in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langford's median patient age at 71, with 62% women.

In 2024, Dr. Langford wrote 155 Medicare Part D claims for 117 patients. 94% of them were for generic drugs. CMS names the drug for 112 of them, across 4 drugs with 11 or more claims each, at $567 in total drug cost. In 2023, CMS named 261 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Langford for performance year 2024, reported as part of a group. Dr. Langford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of hip replacement by Dr. Langford, more than 82% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Dr. Langford, published from 2012 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Fractures, Bone, Fracture Fixation, Internal and Fracture Fixation, Intramedullary. Dr. Langford has published most often in J Orthop Trauma. Dr. Langford's most frequent co-authors are George John Haidukewych, MD, Frank Roman Avilucea, MD and Kenneth J. Koval, MD.

Dmand AI links Dr. Langford to 5 clinical trials. Conditions studied include Foot Injuries, Fractures, Open and Tibial Fractures. Major Extremity Trauma Research Consortium sponsors the most, 4.

CMS Open Payments shows 621 general payments to Dr. Langford from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Stryker Corporation paid the most, $655,481.

Dr. Langford graduated from University of Illinois College of Medicine - Chicago in 2002.

Dr. Langford is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.